chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 84.0
Sex: F
Vaccine: UNK
Symptoms: Dry mouth, Fungal test, Oral discomfort, Skin exfoliation, Tongue discomfort
Clinical narrative: After receiving my second vaccination of Pfizer-BionTech Covid 19 injection, I have the following side effect. 1.Burning of the Tongue and mouth, Sluffing of the mouth skin, and Flim over Teeth, and Dry Mouth.
Age: 16.0
Sex: F
Vaccine: COVID19
Symptoms: Central nervous system lesion, Imaging procedure abnormal, Protein total, White blood cell count normal
Clinical narrative: see prior
Age: 27.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Chills, Fatigue, Frequent bowel movements, Headache
Clinical narrative: Pooping 5 times per day (not diarrhea), fatigue, weakness, chills, intense muscle aches and intense headache.
Age: 27.0
Sex: M
Vaccine: COVID19
Symptoms: Myalgia
Clinical narrative: Pooping 5 times per day (not diarrhea), fatigue, weakness, chills, intense muscle aches and intense headache.
Age: 19.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Headache, Injection site pain, Myalgia
Clinical narrative: Injection site pain, headache, fatigue, muscle pain.
Age: 47.0
Sex: M
Vaccine: COVID19
Symptoms: Condition aggravated, Tinnitus
Clinical narrative: Extreme Tinnitus
Age: 33.0
Sex: M
Vaccine: COVID19
Symptoms: Tinnitus
Clinical narrative: I have tinnitus in both ears. I keep hearing loud, very high pitched ring.
Age: 59.0
Sex: M
Vaccine: COVID19
Symptoms: Dysphagia, Feeling abnormal, Hypoaesthesia oral, Paraesthesia
Clinical narrative: SON OF PATIENT CALLED TO CANCEL 2ND DOSE APPOINTMENT STATING PATIENT HAD STRANGE FEELING FROM HIS SHOULDER TO HIS HAND IMMEDIATELY AFTER VACCINE, THEN 13 MINUTES LATER HAD TINGLING IN HIS FACE AND NUMBNESS IN HIS TONGUE. HE WAS TAKEN TO THE EMERGENCY ROOM WHERE HE WAS UNABLE TO CONSUME WATER BECAUSE OF ADVERSE EFFECTS
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Blood electrolytes, Blood test, Burning sensation, Drug reaction with eosinophilia and systemic symptoms, Erythema
Clinical narrative: Exact same symptoms as with DRESS syndrome - swollen, itchy eyes; red, burning sensation on skin on face
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Eye pruritus, Eye swelling, Full blood count
Clinical narrative: Exact same symptoms as with DRESS syndrome - swollen, itchy eyes; red, burning sensation on skin on face
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site pain, Injection site swelling
Clinical narrative: pt arm very sore/swollen @ inj. site. Pt taking around the clock ibuprofen for past 2days & massaged area. Also altern w/hot & cold compress.
Age: 34.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Headache, Myalgia, Nausea
Clinical narrative: NON. INTRACTABLE HEAD ACHE MYALGIA NAUSEA CHILLS  REPORTED 4 DAYS POST VACCINE
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Blood glucose increased, Consciousness fluctuating
Clinical narrative: PATIENT HAD BEEN SHOPPING IN THE STORE AND WAS IN AND OUT OF CONSCIOUSNESS WHEN I WAS CALLED OVER FROM THE PHARMACY TO CHECK ON HIM. PT ALSO USES OXYGEN AT HOME AND DID NOT BRING WITH HIM. BLOOD SUGAR WAS HIGH (>220) AND PARAMETICS ARRIVED ON SCENE AND TOOK HIM INTO AMBULANCE TO BE EVALUATED. THEY WERE NOTIFIED THAT HE RECEIVED VACCINE APPROXIMATELY 1 HOUR BEFORE EVENT.
Age: 25.0
Sex: M
Vaccine: COVID19
Symptoms: Dizziness, Head injury, Loss of consciousness
Clinical narrative: Patient passed out around 5 minutes after receiving the second dose of the Moderna vaccine. He hit his head hard on the ground and felt dizzy and lightheaded for about 15 minutes after the fall.
Sex: F
Vaccine: COVID19
Symptoms: Loss of consciousness
Clinical narrative: About 5 mins after vaccine administration patient passed out. She came back to a few seconds later. 911 called EMS examined her & she went home
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Psychotic disorder
Clinical narrative: Narrative:  Patient was hospitalized to agency hospital on 5/11/2021 d/t psychosis. No reported ADR since receiving COVID-19 vaccine. Symptoms:  & HOSPITALIZATION Treatment:
Age: 58.0
Sex: M
Vaccine: COVID19
Symptoms: Disorientation, Dizziness, Fall, Gait disturbance, Incoherent
Clinical narrative: At approximately 1338 Patient had finished 30 minutes observation following the 1st dose of Moderna COVID vaccine. Patient stood up and immediately became dizzy, stumbled twice, and started to fall. Two nurse assisted Patient to the ground, protecting patient's head. Patient was not coherent or answering questions appropriately. At 1339 Rapid response Team was called. Staff attempted to get vitals and blood glucose. Patient was not cooperating and disoriented. Patient was attempting to sit up and stand despites staffs effort to encourage to stay laying down. Rapid Response Team arrived and took over. Patient was assisted to gurney and taken to ED.  Dizziness & Seizure like activity
Age: 58.0
Sex: M
Vaccine: COVID19
Symptoms: Patient uncooperative, Seizure like phenomena
Clinical narrative: At approximately 1338 Patient had finished 30 minutes observation following the 1st dose of Moderna COVID vaccine. Patient stood up and immediately became dizzy, stumbled twice, and started to fall. Two nurse assisted Patient to the ground, protecting patient's head. Patient was not coherent or answering questions appropriately. At 1339 Rapid response Team was called. Staff attempted to get vitals and blood glucose. Patient was not cooperating and disoriented. Patient was attempting to sit up and stand despites staffs effort to encourage to stay laying down. Rapid Response Team arrived and took over. Patient was assisted to gurney and taken to ED.  Dizziness & Seizure like activity
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: 60 yo female with PMH of hypothyroidism, overweight, osteopenia, basal cell carcinoma, hep C, alcohol dependence, and schizophrenia reported having a mild rash on uppper thighs that lasted one day after her first dose of covid-19 vaccine, 2/8/2021. Pt reported this ADR on 3/1/2021 when she came back for his second dose. Both were administered without complications & RASH ON THIGHS
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Tachycardia
Clinical narrative: Tachycardia & within 15 minutes of administration but subsided 30-40 minutes after vaccination
Age: 32.0
Sex: M
Vaccine: COVID19
Symptoms: Adverse drug reaction, COVID-19, Diarrhoea, Dizziness, Fatigue
Clinical narrative: 32 yo male with PMH of TBI, OSA, insomnia, migraine, irriitability and anger, obesity, abnormal LFTs, chronic back pain, and PTSD reported having injection site pain, diarrhea, fatigue, body aches, dizziness after his first dose of pfizer covid-19 vaccine on 2/17/2021. He took tylenol and eletriptan for headaches but did not resolve. Pt went to the ED on 2/20/21 and tested positive for covid-19. Pt reported this ADR on 3/10/2021, when he completed this second dose of covid-19 vaccine. Headache, Fever, Diarrhea, NauseaVomiting &fatigue, generalized aches and pain, injection site pain
Age: 32.0
Sex: M
Vaccine: COVID19
Symptoms: Headache, Injection site pain, Nausea, Pain, Pyrexia
Clinical narrative: 32 yo male with PMH of TBI, OSA, insomnia, migraine, irriitability and anger, obesity, abnormal LFTs, chronic back pain, and PTSD reported having injection site pain, diarrhea, fatigue, body aches, dizziness after his first dose of pfizer covid-19 vaccine on 2/17/2021. He took tylenol and eletriptan for headaches but did not resolve. Pt went to the ED on 2/20/21 and tested positive for covid-19. Pt reported this ADR on 3/10/2021, when he completed this second dose of covid-19 vaccine. Headache, Fever, Diarrhea, NauseaVomiting &fatigue, generalized aches and pain, injection site pain
Age: 32.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive, Vomiting
Clinical narrative: 32 yo male with PMH of TBI, OSA, insomnia, migraine, irriitability and anger, obesity, abnormal LFTs, chronic back pain, and PTSD reported having injection site pain, diarrhea, fatigue, body aches, dizziness after his first dose of pfizer covid-19 vaccine on 2/17/2021. He took tylenol and eletriptan for headaches but did not resolve. Pt went to the ED on 2/20/21 and tested positive for covid-19. Pt reported this ADR on 3/10/2021, when he completed this second dose of covid-19 vaccine. Headache, Fever, Diarrhea, NauseaVomiting &fatigue, generalized aches and pain, injection site pain
Age: 85.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Dysphonia, Nasopharyngitis, Rhinorrhoea, SARS-CoV-2 test positive
Clinical narrative: Narrative:  POSITVE COVID TEST REPORTED BY PATIENT ON 4/9/21; RECEIVED 2ND PFIZER DOSE ON 2/16/21. MILD SYMPTOMS INCLUDE "RASPY VOICE, HEAD COLD, AND RUNNY NOSE". NO HOSPITALIZATION REQUIRED. Symptoms:  & PATIENT REPORTS "head cold, runny nose, raspy voice" Treatment:
Age: 66.0
Sex: F
Vaccine: FLU4, FLU4
Symptoms: Asthenia, Pain, Pain in extremity
Clinical narrative: Immediate pain in the injection site. Sharp pain lasting for weeks after injection. Visited doctor after two weeks of weakness and pain. The doctor indicated that the shot was likely injected into the bursa in my shoulder and referred me to an MRI. Results of the MRI showed inflammation and cyst on the bursa of my left shoulder.
Age: 66.0
Sex: F
Vaccine: FLU4, FLU4
Symptoms: Asthenia, Bursitis, Cyst, Immediate post-injection reaction, Incorrect route of product administration
Clinical narrative: Immediate pain in the injection site. Sharp pain lasting for weeks after injection. Visited doctor after two weeks of weakness and pain. The doctor indicated that the shot was likely injected into the bursa in my shoulder and referred me to an MRI. Results of the MRI showed inflammation and cyst on the bursa of my left shoulder.
Age: 66.0
Sex: F
Vaccine: FLU4, FLU4
Symptoms: Inflammation, Injection site pain, Magnetic resonance imaging joint, Pain
Clinical narrative: Immediate pain in the injection site. Sharp pain lasting for weeks after injection. Visited doctor after two weeks of weakness and pain. The doctor indicated that the shot was likely injected into the bursa in my shoulder and referred me to an MRI. Results of the MRI showed inflammation and cyst on the bursa of my left shoulder.
Age: 86.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Angiogram normal, Aphasia, Cardiomegaly, Cerebrovascular accident, Echocardiogram abnormal
Clinical narrative: Stroke 5 days in hospital heart  monitor for 30 days
Age: 86.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Glycosylated haemoglobin normal, Magnetic resonance imaging head abnormal
Clinical narrative: Stroke 5 days in hospital heart  monitor for 30 days
Age: 86.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Blood test, Cerebrovascular accident, Magnetic resonance imaging
Clinical narrative: Stroke 5 days in hospital heart  monitor for 30 days
Age: 86.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Cardiac monitoring, Cerebrovascular accident
Clinical narrative: Stroke 5 days in hospital heart  monitor for 30 days
Age: 37.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Cellulitis
Clinical narrative: She got her vaccine, her got so swollen at the bottom like a lymph node, the swelling would not go down and she could stretch it out.  She cannot lift anything with it, she could not wear a bra and was not able to work for 2 weeks due to this.  Her doctor her a blood thinner and something for the pain, and sent her for blood work.  Then after that the knot went down but not completely.  She came back to work but every time she moves her arm she feels up to now.  On the left arm under the armpit it is still swollen and now has two abnormal arms, one is flat and one is pouched out on the left arm.   She went to the doctor last month and they told her that she needs to have a biopsy as they do not know what it is.  The swelling has gone down but still has the bump and her arm does not look like it did before she had the vaccine.    She did have the 2nd vaccine in the right arm, and had no reaction other than some pain the next day on the bottom of her arm and that was it.  She did not have the discomfort that she had from the first one.
Age: 37.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Blood test, Impaired work ability, Lymphadenopathy, Mobility decreased, Nodule
Clinical narrative: She got her vaccine, her got so swollen at the bottom like a lymph node, the swelling would not go down and she could stretch it out.  She cannot lift anything with it, she could not wear a bra and was not able to work for 2 weeks due to this.  Her doctor her a blood thinner and something for the pain, and sent her for blood work.  Then after that the knot went down but not completely.  She came back to work but every time she moves her arm she feels up to now.  On the left arm under the armpit it is still swollen and now has two abnormal arms, one is flat and one is pouched out on the left arm.   She went to the doctor last month and they told her that she needs to have a biopsy as they do not know what it is.  The swelling has gone down but still has the bump and her arm does not look like it did before she had the vaccine.    She did have the 2nd vaccine in the right arm, and had no reaction other than some pain the next day on the bottom of her arm and that was it.  She did not have the discomfort that she had from the first one.
Age: 37.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Swelling
Clinical narrative: She got her vaccine, her got so swollen at the bottom like a lymph node, the swelling would not go down and she could stretch it out.  She cannot lift anything with it, she could not wear a bra and was not able to work for 2 weeks due to this.  Her doctor her a blood thinner and something for the pain, and sent her for blood work.  Then after that the knot went down but not completely.  She came back to work but every time she moves her arm she feels up to now.  On the left arm under the armpit it is still swollen and now has two abnormal arms, one is flat and one is pouched out on the left arm.   She went to the doctor last month and they told her that she needs to have a biopsy as they do not know what it is.  The swelling has gone down but still has the bump and her arm does not look like it did before she had the vaccine.    She did have the 2nd vaccine in the right arm, and had no reaction other than some pain the next day on the bottom of her arm and that was it.  She did not have the discomfort that she had from the first one.
Age: 33.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Chills, Fatigue, Headache, Nausea, Pain
Clinical narrative: Fever up to 101; chills; body aches; fatigue; This is a spontaneous report from a contactable consumer (patient herself). A 33-year-old non-pregnant female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection Batch/Lot Number: EL9264), via an unspecified route of administration, administered in Arm Left on 08Feb2021 10:45 as 2nd dose single for covid-19 immunisation. Patient previously received BNT162B2 for Covid-19 immunization (lot number=EL3247, administration time=01:00 PM, vaccine location=Left arm, dose number=1)Medical history included thyroid cancer from 2018 and unknown if ongoing and seizure and allergies to medications, food, or other products was reported as none. Concomitant medication included levothyroxine sodium (SYNTHROID) and levetiracetam (KEPPRA). The patient was not diagnosed with COVID-19 before vaccination and it is unknown if the patient diagnose with COVID-19 after the vaccination. On 09Feb2021 at 07:00, the patient experienced fever up to 101, chills, body aches and fatigue. The patient underwent lab tests and procedures which included body temperature: on 09Feb2021 Fever up to 101. Therapeutic measures were taken as a result of the events with advil and tylenol. The outcome of the event were recovering.  Follow-up (12May2021): Follow-up attempts completed. No further information expected.
Age: 33.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pyrexia
Clinical narrative: Fever up to 101; chills; body aches; fatigue; This is a spontaneous report from a contactable consumer (patient herself). A 33-year-old non-pregnant female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection Batch/Lot Number: EL9264), via an unspecified route of administration, administered in Arm Left on 08Feb2021 10:45 as 2nd dose single for covid-19 immunisation. Patient previously received BNT162B2 for Covid-19 immunization (lot number=EL3247, administration time=01:00 PM, vaccine location=Left arm, dose number=1)Medical history included thyroid cancer from 2018 and unknown if ongoing and seizure and allergies to medications, food, or other products was reported as none. Concomitant medication included levothyroxine sodium (SYNTHROID) and levetiracetam (KEPPRA). The patient was not diagnosed with COVID-19 before vaccination and it is unknown if the patient diagnose with COVID-19 after the vaccination. On 09Feb2021 at 07:00, the patient experienced fever up to 101, chills, body aches and fatigue. The patient underwent lab tests and procedures which included body temperature: on 09Feb2021 Fever up to 101. Therapeutic measures were taken as a result of the events with advil and tylenol. The outcome of the event were recovering.  Follow-up (12May2021): Follow-up attempts completed. No further information expected.
Age: 33.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Body temperature, Chills, Fatigue, Pain, Pyrexia
Clinical narrative: Fever up to 101; chills; body aches; fatigue; This is a spontaneous report from a contactable consumer (patient herself). A 33-year-old non-pregnant female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection Batch/Lot Number: EL9264), via an unspecified route of administration, administered in Arm Left on 08Feb2021 10:45 as 2nd dose single for covid-19 immunisation. Patient previously received BNT162B2 for Covid-19 immunization (lot number=EL3247, administration time=01:00 PM, vaccine location=Left arm, dose number=1)Medical history included thyroid cancer from 2018 and unknown if ongoing and seizure and allergies to medications, food, or other products was reported as none. Concomitant medication included levothyroxine sodium (SYNTHROID) and levetiracetam (KEPPRA). The patient was not diagnosed with COVID-19 before vaccination and it is unknown if the patient diagnose with COVID-19 after the vaccination. On 09Feb2021 at 07:00, the patient experienced fever up to 101, chills, body aches and fatigue. The patient underwent lab tests and procedures which included body temperature: on 09Feb2021 Fever up to 101. Therapeutic measures were taken as a result of the events with advil and tylenol. The outcome of the event were recovering.  Follow-up (12May2021): Follow-up attempts completed. No further information expected.
Age: 65.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Asthenia, Blood pressure increased, Chills, Influenza like illness, Mobility decreased
Clinical narrative: itchy all over in both arms, face, high blood pressure, dizziness, hives
Age: 65.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pruritus, Pyrexia, Retching
Clinical narrative: itchy all over in both arms, face, high blood pressure, dizziness, hives
Age: 65.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dizziness, Hypertension, Pruritus, Urticaria
Clinical narrative: itchy all over in both arms, face, high blood pressure, dizziness, hives
Age: 72.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Guillain-Barre syndrome, Lumbar puncture, Magnetic resonance imaging spinal
Clinical narrative: Roughly 48 hours after second shot of Modern COVID19 vaccine (lot 013L20A) on 2/14/2021 started to notice motor weakness and loss sensation in legs adding to generalized weakness post-vaccine, on 2/17/2021 went to  Hospital (DC) emergency room because patient identified symptoms as ascending paralysis of lower extremities, 2/17/2021 physical exam revealed Guillan-Barre syndrome w/ flaccid paralysis of lower extremities, sensory deficit, and absent deep tendon reflexes, MRI of brain through lumbar spine were within normal limits other than minor degenerative changes, lumbar puncture w/in normal limits, received 5 doses of IVIG starting on 2/18/2021, primary evaluation and treatment at hospital by  NP-C and Dr.  of  Stroke Unit, on 2/25/2021 was transferred to  Rehabilitation Hospital (DC), released  on 3/5/2021 w/ plan for  in-home health physical and occupation therapy (continued through 5/6/2021), seen by  NP-C as well as Dr. at rehabilitation hospital   outpatient during April 2021, started outpatient physical and occupational therapy at different Hospital on 5/7/2021, saw  new Dr.   on 5/19/2021
Age: 72.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Areflexia, Asthenia, Diplegia, Guillain-Barre syndrome, Immunoglobulin therapy
Clinical narrative: Roughly 48 hours after second shot of Modern COVID19 vaccine (lot 013L20A) on 2/14/2021 started to notice motor weakness and loss sensation in legs adding to generalized weakness post-vaccine, on 2/17/2021 went to  Hospital (DC) emergency room because patient identified symptoms as ascending paralysis of lower extremities, 2/17/2021 physical exam revealed Guillan-Barre syndrome w/ flaccid paralysis of lower extremities, sensory deficit, and absent deep tendon reflexes, MRI of brain through lumbar spine were within normal limits other than minor degenerative changes, lumbar puncture w/in normal limits, received 5 doses of IVIG starting on 2/18/2021, primary evaluation and treatment at hospital by  NP-C and Dr.  of  Stroke Unit, on 2/25/2021 was transferred to  Rehabilitation Hospital (DC), released  on 3/5/2021 w/ plan for  in-home health physical and occupation therapy (continued through 5/6/2021), seen by  NP-C as well as Dr. at rehabilitation hospital   outpatient during April 2021, started outpatient physical and occupational therapy at different Hospital on 5/7/2021, saw  new Dr.   on 5/19/2021
Age: 72.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Lumbar puncture normal, Magnetic resonance imaging head normal, Magnetic resonance imaging spinal normal, Muscular weakness, Paralysis
Clinical narrative: Roughly 48 hours after second shot of Modern COVID19 vaccine (lot 013L20A) on 2/14/2021 started to notice motor weakness and loss sensation in legs adding to generalized weakness post-vaccine, on 2/17/2021 went to  Hospital (DC) emergency room because patient identified symptoms as ascending paralysis of lower extremities, 2/17/2021 physical exam revealed Guillan-Barre syndrome w/ flaccid paralysis of lower extremities, sensory deficit, and absent deep tendon reflexes, MRI of brain through lumbar spine were within normal limits other than minor degenerative changes, lumbar puncture w/in normal limits, received 5 doses of IVIG starting on 2/18/2021, primary evaluation and treatment at hospital by  NP-C and Dr.  of  Stroke Unit, on 2/25/2021 was transferred to  Rehabilitation Hospital (DC), released  on 3/5/2021 w/ plan for  in-home health physical and occupation therapy (continued through 5/6/2021), seen by  NP-C as well as Dr. at rehabilitation hospital   outpatient during April 2021, started outpatient physical and occupational therapy at different Hospital on 5/7/2021, saw  new Dr.   on 5/19/2021
Age: 72.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Sensory loss
Clinical narrative: Roughly 48 hours after second shot of Modern COVID19 vaccine (lot 013L20A) on 2/14/2021 started to notice motor weakness and loss sensation in legs adding to generalized weakness post-vaccine, on 2/17/2021 went to  Hospital (DC) emergency room because patient identified symptoms as ascending paralysis of lower extremities, 2/17/2021 physical exam revealed Guillan-Barre syndrome w/ flaccid paralysis of lower extremities, sensory deficit, and absent deep tendon reflexes, MRI of brain through lumbar spine were within normal limits other than minor degenerative changes, lumbar puncture w/in normal limits, received 5 doses of IVIG starting on 2/18/2021, primary evaluation and treatment at hospital by  NP-C and Dr.  of  Stroke Unit, on 2/25/2021 was transferred to  Rehabilitation Hospital (DC), released  on 3/5/2021 w/ plan for  in-home health physical and occupation therapy (continued through 5/6/2021), seen by  NP-C as well as Dr. at rehabilitation hospital   outpatient during April 2021, started outpatient physical and occupational therapy at different Hospital on 5/7/2021, saw  new Dr.   on 5/19/2021
Age: 55.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Constipation, Feeling abnormal, Tremor
Clinical narrative: entire body vibrating, at sporadic times; I was basically stoned - like I had taken a large dose of Benadryl; Constipation; This is a spontaneous report received from a contactable consumer (patient) reporting about herself.  A 55-year-old female patient (53 years age at vaccination) received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot Number: EL9269, Expiration date not reported), via an unspecified route of administration, in left arm on 05Feb2021 at 19:30 as single dose for COVID-19 immunisation. The patient was not pregnant at the time of report. The patient's medical history included heart condition of Mitral Valve Prolapse (MVP) since an unknown date and unknown if ongoing. She had known allergies (experienced drug hypersensitivity) to drugs namely Ultram, Zofran, Letrozole and Anastrozole. She was not diagnosed with COVID-19 prior vaccination. She did not receive other vaccine within four weeks of vaccination. The patient's concomitant medications included Tamoxifen, Vitamin D3 and Multi Vitamins taken during unspecified two weeks for unknown indication. Following the vaccination on 05Feb2021 at 20:15, the patient started feeling abnormal basically stoned - like she had taken a large dose of Benadryl, followed by her entire body vibrating, at sporadic times and then constipation. The events resulted in visit to a doctor or other healthcare professional office/clinic. There were no therapeutic measures reported at the time of report. The patient did not undergo COVID test post vaccination. The outcome of the event "feeling abnormal basically stoned - like she had taken a large dose of Benadryl" was reported to be recovered on the noon of 07Feb2021 (Sunday) and outcome of the rest two events was reported as not recovered.  Follow-up attempts completed. No further information expected.
Age: 55.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Constipation, Feeling abnormal, Nervousness
Clinical narrative: entire body vibrating, at sporadic times; I was basically stoned - like I had taken a large dose of Benadryl; Constipation; This is a spontaneous report received from a contactable consumer (patient) reporting about herself.  A 55-year-old female patient (53 years age at vaccination) received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot Number: EL9269, Expiration date not reported), via an unspecified route of administration, in left arm on 05Feb2021 at 19:30 as single dose for COVID-19 immunisation. The patient was not pregnant at the time of report. The patient's medical history included heart condition of Mitral Valve Prolapse (MVP) since an unknown date and unknown if ongoing. She had known allergies (experienced drug hypersensitivity) to drugs namely Ultram, Zofran, Letrozole and Anastrozole. She was not diagnosed with COVID-19 prior vaccination. She did not receive other vaccine within four weeks of vaccination. The patient's concomitant medications included Tamoxifen, Vitamin D3 and Multi Vitamins taken during unspecified two weeks for unknown indication. Following the vaccination on 05Feb2021 at 20:15, the patient started feeling abnormal basically stoned - like she had taken a large dose of Benadryl, followed by her entire body vibrating, at sporadic times and then constipation. The events resulted in visit to a doctor or other healthcare professional office/clinic. There were no therapeutic measures reported at the time of report. The patient did not undergo COVID test post vaccination. The outcome of the event "feeling abnormal basically stoned - like she had taken a large dose of Benadryl" was reported to be recovered on the noon of 07Feb2021 (Sunday) and outcome of the rest two events was reported as not recovered.  Follow-up attempts completed. No further information expected.
Sex: F
Vaccine: UNK, COVID19
Symptoms: Lip swelling, Urticaria
Clinical narrative: had a reaction(Attached are pictures of her reaction); having aches and pain.; This is a spontaneous report received from contactable consumer.  A female patient of an unspecified age received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot number was not reported) via an unspecified route of administration on 28Jan2021 at single dose for covid-19 immunisation.  The patient medical history and concomitant medications were not reported. Previously on 06Jan2021, the patient received the first dose of the vaccine for covid-19 immunisation. Patient took the vaccine and first noticed reaction occurred on 29Jan2021; she had a reaction- urticaria (pictures of her reaction reported) that caused her to be on 4 different antihistamines, an injection every four weeks for 6 months. They currently prescribed her Xolair and an EpiPen. The doctors were considering admitting her to the hospital due to it spreading to the bottom of her feet. She was also having aches and pain in 2021.The outcome of the events was unknown. Information on Batch/Lot number has been requested.
Sex: F
Vaccine: UNK, COVID19
Symptoms: Pain in extremity, Urticaria
Clinical narrative: had a reaction(Attached are pictures of her reaction); having aches and pain.; This is a spontaneous report received from contactable consumer.  A female patient of an unspecified age received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot number was not reported) via an unspecified route of administration on 28Jan2021 at single dose for covid-19 immunisation.  The patient medical history and concomitant medications were not reported. Previously on 06Jan2021, the patient received the first dose of the vaccine for covid-19 immunisation. Patient took the vaccine and first noticed reaction occurred on 29Jan2021; she had a reaction- urticaria (pictures of her reaction reported) that caused her to be on 4 different antihistamines, an injection every four weeks for 6 months. They currently prescribed her Xolair and an EpiPen. The doctors were considering admitting her to the hospital due to it spreading to the bottom of her feet. She was also having aches and pain in 2021.The outcome of the events was unknown. Information on Batch/Lot number has been requested.
Age: 68.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Cold sweat, Disturbance in attention, Dizziness, Ear discomfort, Ear, nose and throat examination normal
Clinical narrative: Sinus pressure; Blurry vision; Mild headache; Vestibular inflammation; Brain fog; Aches; Head congestion; Sinus infection; This is a spontaneous report from a contactable consumer, the patient. A 68-year-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN), via an unspecified route of administration in the unspecified anatomical site on an unknown date (at the age of 68-years-old), as a first single dose for COVID-19 vaccination. The patient's medical history included hypothyroid (without medications), hypertension (without medications) and pre-diabetic. The patient felt nauseous while receiving Tetracycline (MANUFACTURER UNKNOWN) and Demerol (MANUFACTURER UNKNOWN) on an unknown date. It was unknown if the patient was diagnosed with COVID-19, prior to the vaccination.  Since the vaccination, the patient had not been tested for COVID-19. Concomitant medications of the patient included Metformin 750 mg (MANUFACTURER UNKNOWN), Losartan 50 mg (MANUFACTURER UNKNOWN) and Synthroid (MANUFACTURER UNKNOWN); all for unknown indication since unknown date and is unknown if ongoing. The patient did not receive any other vaccines within 4 weeks prior to vaccination. On 22Feb2021 at 8:00 (after 1st dose of COVID vaccine), the patient experienced mild headache and aches at 8 hours (post vaccination), got severe vertigo/nausea at approximately 20 hours (post vaccination). The patient had head congestion, blurry vision, sinus pressure and 'brain fog'. The patient further experienced severe vertigo/nausea which improved to moderate by day 4 but suddenly came back when she was exercising. Severe nausea caused vomiting on day 4 and continued 3 days. The vertigo became more moderate after day 7. The patient developed raw swollen throat on left side that is sinus infection by day 9-10. Head congestion and 'brain fog' persisted but diminished over next week. The patient went to ENT for vertigo exam. It was observed that her ears and hearing was fine and healthy. But the patient was diagnosed with probable vestibular inflammation. Vertigo and brain fog worsened and lessened off and on until about day 18. Since day 18 vertigo had been diminished but was still present. At day 23 brain fog was mostly gone, but the patient still had mild vertigo when bending over, lying down or rolling over in bed. The patient cancelled 2nd dose appointment until being well. The patient was treated with antibiotic for sinus and raw throat on day 11. The clinical outcome of aches, brain fog, head congestion, vestibular inflammation, mild headache, blurry vision, sinus pressure was recovering and of sinus infection was unknown. Information about lot/batch number cannot be obtained. No further information is expected.
Age: 68.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Feeling abnormal, Feeling cold, Gait disturbance, Head discomfort, Headache
Clinical narrative: Sinus pressure; Blurry vision; Mild headache; Vestibular inflammation; Brain fog; Aches; Head congestion; Sinus infection; This is a spontaneous report from a contactable consumer, the patient. A 68-year-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN), via an unspecified route of administration in the unspecified anatomical site on an unknown date (at the age of 68-years-old), as a first single dose for COVID-19 vaccination. The patient's medical history included hypothyroid (without medications), hypertension (without medications) and pre-diabetic. The patient felt nauseous while receiving Tetracycline (MANUFACTURER UNKNOWN) and Demerol (MANUFACTURER UNKNOWN) on an unknown date. It was unknown if the patient was diagnosed with COVID-19, prior to the vaccination.  Since the vaccination, the patient had not been tested for COVID-19. Concomitant medications of the patient included Metformin 750 mg (MANUFACTURER UNKNOWN), Losartan 50 mg (MANUFACTURER UNKNOWN) and Synthroid (MANUFACTURER UNKNOWN); all for unknown indication since unknown date and is unknown if ongoing. The patient did not receive any other vaccines within 4 weeks prior to vaccination. On 22Feb2021 at 8:00 (after 1st dose of COVID vaccine), the patient experienced mild headache and aches at 8 hours (post vaccination), got severe vertigo/nausea at approximately 20 hours (post vaccination). The patient had head congestion, blurry vision, sinus pressure and 'brain fog'. The patient further experienced severe vertigo/nausea which improved to moderate by day 4 but suddenly came back when she was exercising. Severe nausea caused vomiting on day 4 and continued 3 days. The vertigo became more moderate after day 7. The patient developed raw swollen throat on left side that is sinus infection by day 9-10. Head congestion and 'brain fog' persisted but diminished over next week. The patient went to ENT for vertigo exam. It was observed that her ears and hearing was fine and healthy. But the patient was diagnosed with probable vestibular inflammation. Vertigo and brain fog worsened and lessened off and on until about day 18. Since day 18 vertigo had been diminished but was still present. At day 23 brain fog was mostly gone, but the patient still had mild vertigo when bending over, lying down or rolling over in bed. The patient cancelled 2nd dose appointment until being well. The patient was treated with antibiotic for sinus and raw throat on day 11. The clinical outcome of aches, brain fog, head congestion, vestibular inflammation, mild headache, blurry vision, sinus pressure was recovering and of sinus infection was unknown. Information about lot/batch number cannot be obtained. No further information is expected.
Age: 68.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Hypertension, Impaired driving ability, Nausea, Pain, Paranasal sinus discomfort
Clinical narrative: Sinus pressure; Blurry vision; Mild headache; Vestibular inflammation; Brain fog; Aches; Head congestion; Sinus infection; This is a spontaneous report from a contactable consumer, the patient. A 68-year-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN), via an unspecified route of administration in the unspecified anatomical site on an unknown date (at the age of 68-years-old), as a first single dose for COVID-19 vaccination. The patient's medical history included hypothyroid (without medications), hypertension (without medications) and pre-diabetic. The patient felt nauseous while receiving Tetracycline (MANUFACTURER UNKNOWN) and Demerol (MANUFACTURER UNKNOWN) on an unknown date. It was unknown if the patient was diagnosed with COVID-19, prior to the vaccination.  Since the vaccination, the patient had not been tested for COVID-19. Concomitant medications of the patient included Metformin 750 mg (MANUFACTURER UNKNOWN), Losartan 50 mg (MANUFACTURER UNKNOWN) and Synthroid (MANUFACTURER UNKNOWN); all for unknown indication since unknown date and is unknown if ongoing. The patient did not receive any other vaccines within 4 weeks prior to vaccination. On 22Feb2021 at 8:00 (after 1st dose of COVID vaccine), the patient experienced mild headache and aches at 8 hours (post vaccination), got severe vertigo/nausea at approximately 20 hours (post vaccination). The patient had head congestion, blurry vision, sinus pressure and 'brain fog'. The patient further experienced severe vertigo/nausea which improved to moderate by day 4 but suddenly came back when she was exercising. Severe nausea caused vomiting on day 4 and continued 3 days. The vertigo became more moderate after day 7. The patient developed raw swollen throat on left side that is sinus infection by day 9-10. Head congestion and 'brain fog' persisted but diminished over next week. The patient went to ENT for vertigo exam. It was observed that her ears and hearing was fine and healthy. But the patient was diagnosed with probable vestibular inflammation. Vertigo and brain fog worsened and lessened off and on until about day 18. Since day 18 vertigo had been diminished but was still present. At day 23 brain fog was mostly gone, but the patient still had mild vertigo when bending over, lying down or rolling over in bed. The patient cancelled 2nd dose appointment until being well. The patient was treated with antibiotic for sinus and raw throat on day 11. The clinical outcome of aches, brain fog, head congestion, vestibular inflammation, mild headache, blurry vision, sinus pressure was recovering and of sinus infection was unknown. Information about lot/batch number cannot be obtained. No further information is expected.
Age: 68.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Sensation of foreign body, Sinus congestion, Sinusitis, Throat irritation, Tremor
Clinical narrative: Sinus pressure; Blurry vision; Mild headache; Vestibular inflammation; Brain fog; Aches; Head congestion; Sinus infection; This is a spontaneous report from a contactable consumer, the patient. A 68-year-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN), via an unspecified route of administration in the unspecified anatomical site on an unknown date (at the age of 68-years-old), as a first single dose for COVID-19 vaccination. The patient's medical history included hypothyroid (without medications), hypertension (without medications) and pre-diabetic. The patient felt nauseous while receiving Tetracycline (MANUFACTURER UNKNOWN) and Demerol (MANUFACTURER UNKNOWN) on an unknown date. It was unknown if the patient was diagnosed with COVID-19, prior to the vaccination.  Since the vaccination, the patient had not been tested for COVID-19. Concomitant medications of the patient included Metformin 750 mg (MANUFACTURER UNKNOWN), Losartan 50 mg (MANUFACTURER UNKNOWN) and Synthroid (MANUFACTURER UNKNOWN); all for unknown indication since unknown date and is unknown if ongoing. The patient did not receive any other vaccines within 4 weeks prior to vaccination. On 22Feb2021 at 8:00 (after 1st dose of COVID vaccine), the patient experienced mild headache and aches at 8 hours (post vaccination), got severe vertigo/nausea at approximately 20 hours (post vaccination). The patient had head congestion, blurry vision, sinus pressure and 'brain fog'. The patient further experienced severe vertigo/nausea which improved to moderate by day 4 but suddenly came back when she was exercising. Severe nausea caused vomiting on day 4 and continued 3 days. The vertigo became more moderate after day 7. The patient developed raw swollen throat on left side that is sinus infection by day 9-10. Head congestion and 'brain fog' persisted but diminished over next week. The patient went to ENT for vertigo exam. It was observed that her ears and hearing was fine and healthy. But the patient was diagnosed with probable vestibular inflammation. Vertigo and brain fog worsened and lessened off and on until about day 18. Since day 18 vertigo had been diminished but was still present. At day 23 brain fog was mostly gone, but the patient still had mild vertigo when bending over, lying down or rolling over in bed. The patient cancelled 2nd dose appointment until being well. The patient was treated with antibiotic for sinus and raw throat on day 11. The clinical outcome of aches, brain fog, head congestion, vestibular inflammation, mild headache, blurry vision, sinus pressure was recovering and of sinus infection was unknown. Information about lot/batch number cannot be obtained. No further information is expected.
Age: 68.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Vertigo, Vision blurred, Vomiting
Clinical narrative: Sinus pressure; Blurry vision; Mild headache; Vestibular inflammation; Brain fog; Aches; Head congestion; Sinus infection; This is a spontaneous report from a contactable consumer, the patient. A 68-year-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN), via an unspecified route of administration in the unspecified anatomical site on an unknown date (at the age of 68-years-old), as a first single dose for COVID-19 vaccination. The patient's medical history included hypothyroid (without medications), hypertension (without medications) and pre-diabetic. The patient felt nauseous while receiving Tetracycline (MANUFACTURER UNKNOWN) and Demerol (MANUFACTURER UNKNOWN) on an unknown date. It was unknown if the patient was diagnosed with COVID-19, prior to the vaccination.  Since the vaccination, the patient had not been tested for COVID-19. Concomitant medications of the patient included Metformin 750 mg (MANUFACTURER UNKNOWN), Losartan 50 mg (MANUFACTURER UNKNOWN) and Synthroid (MANUFACTURER UNKNOWN); all for unknown indication since unknown date and is unknown if ongoing. The patient did not receive any other vaccines within 4 weeks prior to vaccination. On 22Feb2021 at 8:00 (after 1st dose of COVID vaccine), the patient experienced mild headache and aches at 8 hours (post vaccination), got severe vertigo/nausea at approximately 20 hours (post vaccination). The patient had head congestion, blurry vision, sinus pressure and 'brain fog'. The patient further experienced severe vertigo/nausea which improved to moderate by day 4 but suddenly came back when she was exercising. Severe nausea caused vomiting on day 4 and continued 3 days. The vertigo became more moderate after day 7. The patient developed raw swollen throat on left side that is sinus infection by day 9-10. Head congestion and 'brain fog' persisted but diminished over next week. The patient went to ENT for vertigo exam. It was observed that her ears and hearing was fine and healthy. But the patient was diagnosed with probable vestibular inflammation. Vertigo and brain fog worsened and lessened off and on until about day 18. Since day 18 vertigo had been diminished but was still present. At day 23 brain fog was mostly gone, but the patient still had mild vertigo when bending over, lying down or rolling over in bed. The patient cancelled 2nd dose appointment until being well. The patient was treated with antibiotic for sinus and raw throat on day 11. The clinical outcome of aches, brain fog, head congestion, vestibular inflammation, mild headache, blurry vision, sinus pressure was recovering and of sinus infection was unknown. Information about lot/batch number cannot be obtained. No further information is expected.
Age: 68.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Feeling abnormal, Headache, Pain, Paranasal sinus discomfort, Sinus congestion
Clinical narrative: Sinus pressure; Blurry vision; Mild headache; Vestibular inflammation; Brain fog; Aches; Head congestion; Sinus infection; This is a spontaneous report from a contactable consumer, the patient. A 68-year-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN), via an unspecified route of administration in the unspecified anatomical site on an unknown date (at the age of 68-years-old), as a first single dose for COVID-19 vaccination. The patient's medical history included hypothyroid (without medications), hypertension (without medications) and pre-diabetic. The patient felt nauseous while receiving Tetracycline (MANUFACTURER UNKNOWN) and Demerol (MANUFACTURER UNKNOWN) on an unknown date. It was unknown if the patient was diagnosed with COVID-19, prior to the vaccination.  Since the vaccination, the patient had not been tested for COVID-19. Concomitant medications of the patient included Metformin 750 mg (MANUFACTURER UNKNOWN), Losartan 50 mg (MANUFACTURER UNKNOWN) and Synthroid (MANUFACTURER UNKNOWN); all for unknown indication since unknown date and is unknown if ongoing. The patient did not receive any other vaccines within 4 weeks prior to vaccination. On 22Feb2021 at 8:00 (after 1st dose of COVID vaccine), the patient experienced mild headache and aches at 8 hours (post vaccination), got severe vertigo/nausea at approximately 20 hours (post vaccination). The patient had head congestion, blurry vision, sinus pressure and 'brain fog'. The patient further experienced severe vertigo/nausea which improved to moderate by day 4 but suddenly came back when she was exercising. Severe nausea caused vomiting on day 4 and continued 3 days. The vertigo became more moderate after day 7. The patient developed raw swollen throat on left side that is sinus infection by day 9-10. Head congestion and 'brain fog' persisted but diminished over next week. The patient went to ENT for vertigo exam. It was observed that her ears and hearing was fine and healthy. But the patient was diagnosed with probable vestibular inflammation. Vertigo and brain fog worsened and lessened off and on until about day 18. Since day 18 vertigo had been diminished but was still present. At day 23 brain fog was mostly gone, but the patient still had mild vertigo when bending over, lying down or rolling over in bed. The patient cancelled 2nd dose appointment until being well. The patient was treated with antibiotic for sinus and raw throat on day 11. The clinical outcome of aches, brain fog, head congestion, vestibular inflammation, mild headache, blurry vision, sinus pressure was recovering and of sinus infection was unknown. Information about lot/batch number cannot be obtained. No further information is expected.